April 1, 2011 -- John Lechlieter, CEO of Lilly, said China currently accounts for just 2% of the company’s revenues, a figure that equates to about $230 million. But he believes the opportunities in China are great as the country becomes the second largest market for pharmaceuticals in the world. For that reason, Lilly is investing heavily in China. More details....
